What was once considered “junk cells” called Atypical B cells (ABCs), might not be junk at all. A new study reveals ABCs are key players in fighting infections like malaria, offering exciting possibilities for new treatments.
Scientists have long observed ABCs in people with diseases like malaria and lupus, but their role was unclear. In this study they were wanting to understand how these cells arise and whether they help or hinder our defences (Figure 1).
The results were surprising – ABCs weren’t just harmless bystanders; they were key in the immune system function. The study found ABCs help in two key ways:
Boosting T cell helpers: These “helper cells” are essential for generating antibodies. ABCs play a vital role in developing these helpers, strengthening the body’s defences against malaria parasites.
Directly attacking the enemy: The study also suggests ABCs might have their own ways of tackling harmful infections, adding another layer to their defensive capabilities.
Using gene-editing, researchers identified a gene called Zeb2. Mice lacking this gene couldn’t control malaria infection, highlighting the crucial role of ABCs in this battle.
The discovery doesn’t just benefit malaria research. Since ABCs also appear in autoimmune diseases like lupus, understanding their role could lead to new treatments to control these conditions.
Journal article: Gao, X., et al. 2024. Zeb2 drives the formation of CD11c + atypical B cells to sustain germinal centers that control persistent infection. Science Immunology.
Summary by Stefan Botha